NASDAQ:IMI Intermolecular (IMI) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IMI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.20▼$1.2050-Day Range$1.20▼$1.2052-Week Range$0.88▼$1.25VolumeN/AAverage Volume57,852 shsMarket Capitalization$59.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Intermolecular alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Intermolecular Stock (NASDAQ:IMI)Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. IMI Stock News HeadlinesNovember 25, 2023 | lse.co.ukAmundi Msci Uk Imi Sri Pab Share Price (C1U.PA)November 25, 2023 | morningstar.comIMI plc IMIApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 27, 2023 | bbc.co.ukMorocco earthquake: Watch aftershocks send rescue teams runningSeptember 24, 2023 | investing.comMSCI ACWI IMI (MIWD000I0PUS)June 22, 2023 | bbc.co.ukSample exam questions - bonding, structure and matterMarch 16, 2023 | bbc.co.ukSimple covalent moleculesMarch 15, 2023 | bbc.co.ukBonding, structure and properties of materialsApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 2, 2023 | uk.finance.yahoo.comMurchinson Issues Letter to Fellow Shareholders Regarding the Urgent Need for Boardroom Change at Nano DimensionJune 6, 2022 | investing.comIMI_old Historical DataOctober 27, 2021 | finance.yahoo.comWeekly 3-Year Low Highlights: STRA, IMI, HXM, SPHSSee More Headlines Receive IMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intermolecular and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2019Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Semiconductors & Related Devices Sub-IndustrySemiconductors Current SymbolNASDAQ:IMI CUSIP45882D10 CIK1311241 Webwww.intermolecular.com Phone408-582-5700FaxN/AEmployees88Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,410,000.00 Net Margins-42.74% Pretax MarginN/A Return on Equity-33.13% Return on Assets-23.82% Debt Debt-to-Equity Ratio0.43 Current Ratio4.74 Quick Ratio4.74 Sales & Book Value Annual Sales$33.66 million Price / Sales1.77 Cash Flow$0.03 per share Price / Cash Flow45.51 Book Value$0.69 per share Price / Book1.74Miscellaneous Outstanding Shares49,760,000Free FloatN/AMarket Cap$59.71 million OptionableNot Optionable Beta0.93 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Christian F. Kramer (Age 57)Pres, CEO & Director Mr. Bill Roeschlein (Age 49)Sr. VP & CFO Mr. Milind WelingSr. VP of Programs & OperationsDr. Karl LittauChief Technology OfficerMr. Joe MontanoSr. VP of Customer EnablementKey CompetitorsGSI TechnologyNASDAQ:GSITQuickLogicNASDAQ:QUIKMobix LabsNASDAQ:MOBXLightPath TechnologiesNASDAQ:LPTHPOET TechnologiesNASDAQ:POETView All Competitors IMI Stock Analysis - Frequently Asked Questions How were Intermolecular's earnings last quarter? Intermolecular Inc (NASDAQ:IMI) released its quarterly earnings results on Thursday, August, 8th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.08. The semiconductor company had revenue of $4.62 million for the quarter. Intermolecular had a negative net margin of 42.74% and a negative trailing twelve-month return on equity of 33.13%. What other stocks do shareholders of Intermolecular own? Based on aggregate information from My MarketBeat watchlists, some companies that other Intermolecular investors own include A.H. Belo (AHC), Aerojet Rocketdyne (AJRD), Antares Pharma (ATRS), Genetic Technologies (GENE), CarMax (KMX), Liquidity Services (LQDT), Orion Energy Systems (OESX), Profire Energy (PFIE), CafePress (PRSS) and Payment Data Systems (PYDS). This page (NASDAQ:IMI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intermolecular Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
